These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 6310538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H.
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of changes in dietary sodium intake on normotensive subjects with and without a genetic predisposition to essential hypertension.
    Weissberg PL, West MJ, Wilkins MR, Kricka LJ.
    J Hypertens Suppl; 1984 Dec; 2(3):S511-3. PubMed ID: 6100752
    [Abstract] [Full Text] [Related]

  • 7. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
    Krzesinski JM, Potier JP, Godon JP, Rorive GL.
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ.
    Scand J Clin Lab Invest Suppl; 1986 Jun; 180():65-71. PubMed ID: 3012764
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of dietary sodium restriction on leucocyte sodium transport in normotensive subjects and in patients with essential hypertension.
    Poston L, Johnson VE, Gray HH, Hilton PJ, Markandu ND, MacGregor GA.
    Klin Wochenschr; 1985 Jun; 63 Suppl 3():136-8. PubMed ID: 3999631
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sodium transport by leucocytes and erythrocytes in hypertensive subjects and their normotensive relatives.
    Gray HH, Johnson VE, Poston L, Hilton PJ.
    J Hypertens Suppl; 1984 Dec; 2(3):S467-9. PubMed ID: 6599701
    [Abstract] [Full Text] [Related]

  • 20. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF, Devynck MA, Elghozi JL, Kamal LA, Lacerda-Jacomini LC, Meyer P, Pernollet MG, Rosenfeld JB, De Thé H.
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.